Becton Dickinson Shares Outstanding 2010-2024 | BDX
Becton Dickinson shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Becton Dickinson shares outstanding for the quarter ending September 30, 2024 were 0.291B, a 0.91% increase year-over-year.
- Becton Dickinson 2024 shares outstanding were 0.291B, a 0.91% increase from 2023.
- Becton Dickinson 2023 shares outstanding were 0.288B, a 0.36% increase from 2022.
- Becton Dickinson 2022 shares outstanding were 0.287B, a 1.62% decline from 2021.
Becton Dickinson Annual Shares Outstanding
(Millions of Shares) |
| 2024 |
291 |
| 2023 |
288 |
| 2022 |
287 |
| 2021 |
292 |
| 2020 |
282 |
| 2019 |
275 |
| 2018 |
265 |
| 2017 |
224 |
| 2016 |
218 |
| 2015 |
208 |
| 2014 |
198 |
| 2013 |
199 |
| 2012 |
209 |
| 2011 |
226 |
| 2010 |
240 |
| 2009 |
247 |
Becton Dickinson Quarterly Shares Outstanding
(Millions of Shares) |
| 2024-09-30 |
291 |
| 2024-06-30 |
290 |
| 2024-03-31 |
290 |
| 2023-12-31 |
291 |
| 2023-09-30 |
288 |
| 2023-06-30 |
288 |
| 2023-03-31 |
286 |
| 2022-12-31 |
285 |
| 2022-09-30 |
287 |
| 2022-06-30 |
287 |
| 2022-03-31 |
287 |
| 2021-12-31 |
287 |
| 2021-09-30 |
292 |
| 2021-06-30 |
292 |
| 2021-03-31 |
294 |
| 2020-12-31 |
293 |
| 2020-09-30 |
282 |
| 2020-06-30 |
285 |
| 2020-03-31 |
275 |
| 2019-12-31 |
275 |
| 2019-09-30 |
275 |
| 2019-06-30 |
274 |
| 2019-03-31 |
270 |
| 2018-12-31 |
274 |
| 2018-09-30 |
265 |
| 2018-06-30 |
274 |
| 2018-03-31 |
267 |
| 2017-12-31 |
230 |
| 2017-09-30 |
224 |
| 2017-06-30 |
221 |
| 2017-03-31 |
218 |
| 2016-12-31 |
218 |
| 2016-09-30 |
218 |
| 2016-06-30 |
217 |
| 2016-03-31 |
217 |
| 2015-12-31 |
216 |
| 2015-09-30 |
208 |
| 2015-06-30 |
215 |
| 2015-03-31 |
200 |
| 2014-12-31 |
197 |
| 2014-09-30 |
198 |
| 2014-06-30 |
197 |
| 2014-03-31 |
197 |
| 2013-12-31 |
198 |
| 2013-09-30 |
199 |
| 2013-06-30 |
199 |
| 2013-03-31 |
198 |
| 2012-12-31 |
200 |
| 2012-09-30 |
209 |
| 2012-06-30 |
205 |
| 2012-03-31 |
210 |
| 2011-12-31 |
218 |
| 2011-09-30 |
226 |
| 2011-06-30 |
224 |
| 2011-03-31 |
225 |
| 2010-12-31 |
233 |
| 2010-09-30 |
240 |
| 2010-06-30 |
238 |
| 2010-03-31 |
241 |
| 2009-12-31 |
243 |
| 2009-09-30 |
247 |
| 2009-06-30 |
246 |
| 2009-03-31 |
246 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$64.714B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
